A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

PHASE3CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

July 31, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

exenatide once weekly

subcutaneous injection, 2.0mg, once a week

DRUG

sitagliptin

oral tablet, 100mg, once a day

DRUG

pioglitazone

oral tablet, 45mg, once a day

DRUG

placebo tablet

oral tablet, once a day

DRUG

placebo once weekly

subcutaneous injection, once a week

Trial Locations (62)

Unknown

Research Site, Peoria

Research Site, Artesia

Research Site, Concord

Research Site, Encino

Research Site, Greenbrae

Research Site, La Mesa

Research Site, Orange

Research Site, Walnut Creek

Research Site, Whittier

Research Site, Colorado Springs

Research Site, Washington D.C.

Research Site, Coral Gables

Research Site, DeLand

Research Site, Melbourne

Research Site, Miami

Research Site, New Port Richey

Research Site, Decatur

Research Site, Avon

Research Site, Wichita

Research Site, Paducah

Research Site, Baton Rouge

Research Site, New Orleans

Research Site, Oxon Hill

Research Site, Boston

Research Site, Chelsea

Research Site, Ypsilanti

Research Site, Saint Louis Park

Research Site, St Louis

Research Site, Butte

Research Site, Lincoln

Research Site, Las Vegas

Research Site, New Hyde Park

Research Site, New Windsor

Research Site, New York

Research Site, Rochester

Research Site, Durham

Research Site, Statesville

Research Site, Winston-Salem

Research Site, Athens

Research Site, Cincinnati

Research Site, Dayton

Research Site, Philadelphia

Research Site, Rapid City

Research Site, Memphis

Research Site, Austin

Research Site, Dallas

Research Site, San Antonio

Research Site, Richmond

Research Site, Olympia

Research Site, Spokane

Research Site, Tacoma

Research Site, Bangalore

Research Site, Indore

Research Site, Karnāl

Research Site, Mumbai

Research Site, Pune

Research Site, Guadalajara

Research Site, Zapopan

Research Site, Mexico City

Research Site, Cuernavaca

Research Site, Monterrey

Research Site, Toluca

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

AstraZeneca

INDUSTRY